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Abstract
The actin capping protein (CP) tightly binds to the barbed end of actin filaments, thus playing a key role in actin-based
lamellipodial dynamics. V-1 and CARMIL proteins directly bind to CP and inhibit the filament capping activity of CP. V-1
completely inhibits CP from interacting with the barbed end, whereas CARMIL proteins act on the barbed end-bound CP
and facilitate its dissociation from the filament (called uncapping activity). Previous studies have revealed the striking
functional differences between the two regulators. However, the molecular mechanisms describing how these proteins
inhibit CP remains poorly understood. Here we present the crystal structures of CP complexed with V-1 and with peptides
derived from the CP-binding motif of CARMIL proteins (CARMIL, CD2AP, and CKIP-1). V-1 directly interacts with the primary
actin binding surface of CP, the C-terminal region of the a-subunit. Unexpectedly, the structures clearly revealed the
conformational flexibility of CP, which can be attributed to a twisting movement between the two domains. CARMIL
peptides in an extended conformation interact simultaneously with the two CP domains. In contrast to V-1, the peptides do
not directly compete with the barbed end for the binding surface on CP. Biochemical assays revealed that the peptides
suppress the interaction between CP and V-1, despite the two inhibitors not competing for the same binding site on CP.
Furthermore, a computational analysis using the elastic network model indicates that the interaction of the peptides alters
the intrinsic fluctuations of CP. Our results demonstrate that V-1 completely sequesters CP from the barbed end by simple
steric hindrance. By contrast, CARMIL proteins allosterically inhibit CP, which appears to be a prerequisite for the uncapping
activity. Our data suggest that CARMIL proteins down-regulate CP by affecting its conformational dynamics. This
conceptually new mechanism of CP inhibition provides a structural basis for the regulation of the barbed end elongation in
cells.
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Introduction
The actin capping protein (CP) specifically binds to the barbed
end of actin filaments with a high affinity and prevents the
addition and loss of the monomers at this dynamic end [1,2]. CP is
a heterodimeric protein composed of a- and b-subunits and
the molecule displays a pseudo two-fold symmetry due to the
resemblance of the tertiary structures between the two subunits
[3]. CP caps the filament with its two independent actin binding
sites at the C-terminus of each subunit (‘‘tentacles’’). The tentacles
are functionally non-equivalent: the a-tentacle is more important
than the b-tentacle and is responsible for the initial contact with
the barbed end [4]. A recent cryo-electron microscopy (EM) study
provided a structural model for the barbed end capping by CP [5].
The model depicted the a-tentacle, with its surrounding residues
in the b-subunit, wedged between the two end actin protomers,
which represents the primary contact between CP and actin. A
mutational analysis revealed that three conserved basic residues in
this region, CP (a) Lys256, Arg260, and Arg266 (in the chicken
a1 isoform), are critical for the barbed end capping [5]. The
b-tentacle was predicted to interact with a hydrophobic cleft on
the surface of the terminal protomer to stabilize the capping [5].
A growing body of evidence indicates that CP is a key regulator
of actin-based lamellipodial dynamics. In vitro, CP is one of the
essential proteins required for the formation of the Arp2/3
complex-nucleated branched-actin arrays, which drive lamellipo-
dial protrusion [6]. CP prevents the production of longer filaments
and maintains the cytosolic G-actin pool to promote the Arp2/3
complex-based filament nucleation and branching [7]. In
mammalian cells, CP depletion leads to the explosive formation
PLoS Biology | www.plosbiology.org 1 July 2010 | Volume 8 | Issue 7 | e1000416of filopodia, rather than lamellipodia [8]. Thus, the local
concentration of CP and its affinity to the barbed end are critical
determinants of dendritic actin assembly. The dissociation of CP
from the barbed end is a rare event (t1/2,30 min) in actin
polymerization assays using purified proteins. However, recent
microscopic observations of cultured cells showed that the
fluorescent speckle lifetime of CP bound to actin filament network
structures is on the order of seconds [9,10], suggesting that CP
does not stably cap the barbed end in living cells.
At present, several molecules have been identified that affect the
barbed end capping activity of CP. These regulators can be
categorized in two groups: (1) indirect regulators that bind to actin
filaments and protect the barbed end from CP and (2) direct
regulators that bind CP and modulate its capping activity. Formin
is an indirect regulator because it associates with the barbed end
and allows filament elongation even in the presence of CP [11].
Ena/VASP is also assumed to antagonize the capping activity
without interacting directly with CP [12]. Polyphosphoinositides,
such as PIP2, bind directly to CP and reduce the capping activity
in vitro [13,14].
The V-1 and CARMIL proteins are the only direct CP
regulatory proteins that have been reported. V-1, also known as
myotrophin, is a 13 kDa ankyrin repeat protein that consists of
four ankyrin repeat motifs; two full-repeats are sandwiched
between additional incomplete motifs at each terminus [15]. V-1
has been implicated in a variety of cellular events, including
catecholamine synthesis [16], cerebellar development [17], cardiac
hypertrophy [18], and insulin secretion [19]. Although the precise
functional roles of V-1 in these processes have not been clarified, it
is possible that V-1 acts as a CP regulator in vivo, because V-1 was
found to form a complex with CP in primary-cultured cells and
cell lines in murine cerebella [20,21].
CARMIL is a multi-domain protein that reportedly interacts
with myosin I, Arp2/3 complex, and CP [22]. Down-regulation of
CARMIL resulted in impaired motility in Dictyostelium and
mammalian cells [22,23]. Although CARMIL is a large protein
(,150 kDa), its CP interaction site has been narrowed down to a
small region [23,24], and a ,20 amino acid sequence in this
region [CP-binding motif; LXHXTXXRPK(6X)P] is shared with
other proteins, CD2AP, CIN85, and CKIP-1 [25]. All of these
proteins (CARMIL proteins) can interact with CP via this
consensus motif [25]. CD2AP and its homologue CIN85 are
adaptor proteins involved in various cellular processes, such as T-
cell activation, apoptosis, and actin cytoskeleton dynamics [26].
CKIP-1 interacts with casein kinase 2 and recruits the enzyme to
the plasma membrane [27].
Previous studies have demonstrated that the V-1 and CARMIL
proteins inhibit CP in distinct manners. (1) V-1 bound to CP
blocks actin filament capping, whereas the CP/CARMIL protein
complex has lower barbed end capping activity (KD,15 nM) than
free CP (,1 nM) [23,28,29]. (2) CARMIL acts on the barbed end-
bound CP and facilitates its dissociation from the filament (called
uncapping activity), but V-1 lacks this activity [23,25,28,29]. (3)
The two actin binding sites in CP, the a- and b-tentacles, are not
involved in the CARMIL interaction, whereas V-1 recognizes
these sites [23,28]. (4) The CP binding fragment of CARMIL,
including the CP-binding motif, has little secondary structure. In
contrast, V-1 is a structured ankyrin repeat protein [15,23].
Although previous studies have revealed the striking functional
differences between the two direct CP regulators, the molecular
mechanisms by which these proteins inhibit CP remain poorly
understood. In particular, the mechanism by which the CARMIL
proteins uncap the filament that is tightly bound by CP has
remained enigmatic. In this study, we present the crystal structures
of CP complexed with V-1 and with peptides derived from the CP-
binding motif of CARMIL proteins. Together with biochemical
and computational studies, we have elucidated two distinct
mechanisms for CP regulation by V-1 and CARMIL proteins—
steric hindrance and allosteric restriction of conformational
fluctuations.
Results
In this report, we describe the domain movement of CP. To
facilitate the description, we refer to the structural motifs of CP as
‘‘N-stalk,’’ ‘‘a-globule,’’ ‘‘b-globule,’’ ‘‘central b-sheet,’’ ‘‘antipar-
allel H5s,’’ ‘‘a-tentacle,’’ and ‘‘b-tentacle’’ (Figure 1A; a detailed
description of the motifs is provided in Figure S1).
Crystal Structure of the CP/V-1 Complex
To gain insight into the structural basis for the inhibition of CP
by V-1, we solved the crystal structure of CP (chicken a1/b1) in
complex with V-1 (human). The CP/V-1 complex was crystallized
and the X-ray structure was determined at 2.2 A ˚ resolution
(R=0.186, Rfree=0.237) by molecular replacement, using the CP
structure (PDB: 1IZN) as a search model (Figure 1B and 1C, and
Table S1). CP contacts V-1 at two binding sites: (1) the basic
residues at the C-terminus of the a-subunit and (2) a hydrophobic
pocket adjacent to the basic contact site described above
(Figures 2A and S1).
Three conserved basic residues in the CP a-subunit, Lys256,
Arg260, and Arg266, were shown to be critical for the barbed end
capping [5]. Remarkably, this ‘‘basic triad’’ directly participates in
the V-1 interaction (Figure 2B). Arg260, the center of the ‘‘basic
triad,’’ forms a bidentate salt bridge with V-1 Asp44. In addition,
Lys256 and Arg266 form salt bridges with V-1 Glu78. Further-
more, Lys256 also forms a hydrogen bond with the main chain
oxygen of V-1 Asp44. These notable ion pairs involving the ‘‘basic
triad’’ clearly indicate that V-1 specifically binds conserved
residues important for the interaction with actin, thereby
effectively abolishing the barbed end capping. The importance
Author Summary
Actin is a ubiquitous eukaryotic protein that polymerizes
into bidirectional filaments and plays essential roles in a
variety of biological processes, including cell division,
muscle contraction, neuronal development, and cell
motility. The actin capping protein (CP) tightly binds to
the fast-growing end of the filament (the barbed end) to
block monomer association and dissociation at this end,
thus acting as an important regulator of actin filament
dynamics in cells. Using X-ray crystallography, we present
the atomic structures of CP in complex with fragments of
two inhibitory proteins, V-1 and CARMIL, to compare the
modes of action of these two regulators. The structures
demonstrate that V-1 directly blocks the actin-binding site
of CP, thereby preventing filament capping, whereas
CARMIL functions in a very different manner. Detailed
comparison of several CP structures revealed that CP has
two stable domains that are continuously twisting relative
to each other. CARMIL peptides were found to bind across
the two domains of CP on a surface distinct from its actin
binding sites. We propose that CARMIL peptides attenuate
the binding of CP to actin filaments by suppressing the
twisting movement required for tight barbed end capping.
Our comparative structural studies therefore have revealed
substantial insights in the variety of mechanisms by which
different actin regulatory factors function.
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mutational analysis. We determined the CP/V-1 binding affinity
by surface plasmon resonance measurements. Mutations of
residues which form the ‘‘basic triad,’’ or their ion-pairing residues
in V-1, reduced the affinity more than 25-fold compared with the
wild type proteins (KD=21 nM: binding constants for the mutant
proteins are summarized in Table S2). The effects of mutations in
the ‘‘basic triad’’ on the V-1 interaction are similar to those on the
barbed end capping: reverse-charged mutants have lower affinities
for V-1 than alanine mutants, and multiple mutations exhibit
more severe defects than single mutations [5].
Another striking feature in the CP/V-1 interface is the
hydrophobic contact formed around V-1 Trp8 (Figure 2C). In
V-1, Trp8 on the V-1 helix 1 inserts its indole ring into a
hydrophobic pocket, which is formed by CP (a) Ala257 and
Leu258, immediately adjacent to the ‘‘basic triad,’’ and CP (b)
Gly138 and Ile144 in ‘‘loop S5–S6’’ (a loop connecting b-strands 5
and 6 of the b-subunit). This hydrophobic contact is further
stabilized by a hydrogen bond between the aromatic nitrogen of
the tryptophan and the main chain oxygen of CP (b) Ile144.
Mutation of this tryptophan, V-1 W8A, drastically reduced the
affinity for CP (KD=6.4 mM).
As expected, the CP binding-deficient V-1 did not inhibit CP in
an actin polymerization assay (Figure S2). The wild-type V-1
allowed actin elongation from spectrin-actin seeds, even in the
presence of CP. In contrast, the CP-binding deficient V-1 mutants
(V-1 W8A, D44R, or E78R) had little inhibitory effect on CP
activity.
V-1 Sterically Hinders CP from Capping the Barbed End
We superposed the structure of the CP/V-1 complex onto the
previous EM model of CP on the barbed end of an actin filament
(Figure 3) [5]. This unambiguously demonstrated the collision of a
major part of the V-1 molecule with the filament, mainly with
subdomain 3 of the penultimate protomer. Furthermore, V-1
should prevent CP from even an initial contact with the barbed
end, as it masks the ‘‘a-tentacle’’ by interacting with the ‘‘basic
triad’’ residues (Figure 2B). Collectively, V-1 completely inhibits
CP from interaction with the actin filament. The structure also
indicates that V-1 lacks uncapping activity, because the V-1
binding site on CP is buried deeply between the two end
protomers when CP caps the filaments.
V-1 Overexpression Enhances Actin Polymerization in
PC12D Cells
Although the association of V-1 with CP has been reported in
vivo [20,21], it remains unknown whether V-1 is involved in the
regulation of cellular actin assembly. We addressed this question
Figure 1. Crystal structure of the CP/V-1 complex. (A) The CP structural motifs are shown in different colors. (B and C) Two orthogonal views of
the CP/V-1 complex structure are shown in ribbon models with the V-1 surface. The CP a-subunit, b-subunit, and V-1 are colored yellow, green, and
magenta, respectively.
doi:10.1371/journal.pbio.1000416.g001
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transfected with V-1 cDNA and expresses a 5- to 6-fold higher
amount of V-1 than the mock transfectant C-9 [16]. Initially, we
measured the ratio of F-actin to G-actin by a sedimentation assay
and found that more actin pelleted from extracts of V1-69 cells
than mock cells (Figure 4A). This indicates that the overexpression
of V-1 leads to enhanced actin polymerization in PC12D cells. We
next examined the amount of CP in subcellular fractions. In the
V1-69 cells, the proportion of CP in the ‘‘high speed supernatant’’
fraction was significantly larger than that of the mock transfectant.
This result was inversely correlated with a decrease in the
distribution of the ‘‘high speed pellet insoluble in detergent’’
fraction (Figure 4B: see Materials and Methods for the subcellular
fractionation procedure). The overexpression of V-1 did not alter
the total amount of CP in the transfectants (unpublished data).
These results imply that V-1 enhances actin polymerization by
inhibiting the interaction of CP with the cytoskeleton structures.
Moreover, we observed that, compared to the mock cells, V1-69
cells exhibited membrane protrusive structures with a thick,
neurite-like appearance (Figure 4C). Phalloidin staining revealed
that these protrusions were enriched with actin filaments
(Figure 4C), implying that CP suppression caused by V-1
overexpression leads to the alteration of cell morphology
presumably due to the increase in the level of actin polymerization.
Taken together, our results demonstrate the possible involvement
of V-1 in the regulation of actin polymerization and cellular
morphology in living cells.
CP Consists of Two Rigid Domains and Undergoes
Conformational Changes
With the exception of the mobile ‘‘b-tentacle,’’ CP has been
considered to be a rigid heterodimeric protein that is stabilized by
many intra- and inter-subunit interactions [3]. However, we found
Figure 2. CP/V-1 molecular interface. (A) Residues involved in
intermolecular interactions. V-1 residues contacting the CP a-o rb-
subunit residues are underlined and shown in cyan and orange,
respectively. Interface CP residues are shown as stick models. (B)
Interactions between the CP ‘‘basic triad’’ residues and V-1 Asp44 and
Glu78. Salt bridges and hydrogen bonds are indicated by dotted lines
with distances indicated in angstroms (B and C). (C) Interactions
between V-1 Trp8 and the hydrophobic pocket adjacent to the CP
‘‘basic triad.’’
doi:10.1371/journal.pbio.1000416.g002
Figure 3. V-1 sterically hinders CP from the barbed end.
Superposition of the CP/V-1 complex onto the EM model of the CP/
barbed end structure. The CP/V-1 complex was superposed over the Ca
positions of CP (b) 47–173 in the original CP model. The actin proto-
filament is shown in a surface model (white or gray). The penultimate
protomer (subdomains 1–4 are labeled) is transparent to show the
steric hindrance by V-1.
doi:10.1371/journal.pbio.1000416.g003
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is apparently different from the free form (CPfull; PDB; 1IZN;
Figure 5A); e.g., the ‘‘antiparallel H5s’’ is straighter and the ‘‘N-
stalk’’ and ‘‘b-globule’’ are further apart. Superposition of the two
structures was poor, with a root-mean-square displacement
(RMSD) over the Ca atoms of 2.55 A ˚ [residues 9–275 (a) and
3–244 (b); the ‘‘b-tentacle’’ was not included] (Figure 5C). This
unexpected finding indicates that CP has conformational flexibil-
ity. For further structural comparison, we obtained a new ligand-
free CP structure crystallized under different conditions from
1IZN (CPbDC; at a 1.9 A ˚ resolution) (Figure S3) and found that the
structure of CPbDC is substantially different from both CPfull and
CPV-1 (RMSDs of 1.34 A ˚ and 1.87 A ˚, respectively) (Figure 5C and
Table S3). These values are much larger than those expected for
the same protein crystallized under different conditions (,0.8 A ˚)
[30]. Therefore, we conclude that CP conformational changes are
not induced solely by the binding of a ligand molecule but show
that CP is an intrinsically flexible molecule.
A domain motion analysis revealed that CP comprises two
structurally stable domains, and the conformational change can be
attributed to a twisting movement between the domains
(Figures 5D–G and S4). The larger domain contains roughly
two-thirds of the CP residues [residues 1–258 (a): 1–42, 175–192,
and 235–277 (b)] and consists of the entire ‘‘N-stalk,’’ ‘‘a-globule,’’
and ‘‘b-tentacle’’ motifs together with parts of the ‘‘central b-
sheet’’ and ‘‘antiparallel H5s,’’ whereas the smaller domain
[residues 259–286 (a): 43–174 and 193–234 (b)] consists of the
remaining portion. We refer to these larger and smaller domains
as the CP-L and CP-S domains, respectively. Each domain
superimposed well across the three forms (RMSDs of 0.80–1.06 A ˚
for the CP-L domain and 0.80–1.04 A ˚ for the CP-S domain)
(Table S3). The boundary of the two domains does not directly
correspond to the subunit interface; it resides between the ‘‘N-
stalk’’ and ‘‘b-globule.’’ The two domains are linked by flexible
regions, such as a short linker [Asp43–Leu47 (b)] between the ‘‘N-
stalk’’ and ‘‘b-globule’’ and the helix-breaking residues [Thr253 (a)
Figure 4. Overexpression of V-1 enhances actin polymerization in PC12D cells. (A) F-/G-actin ratio. The amounts of cellular actin in high-
speed supernatants (G-actin) and pellets (F-actin) were quantified by Western blotting using an anti-actin antibody. Values are means 6 SEM (n=3).
Statistical analysis was performed using Student’s t-test (*p,0.05). (B) Subcellular fractionation of CP. ‘‘high speed supernatant (HSS),’’ ‘‘high speed
pellet (HSP) soluble in detergent,’’ and ‘‘high speed pellet insoluble in detergent’’ fractions were prepared (see Materials and Methods) and subjected
to a Western blot analysis, using an anti-CP b antibody (n=3). Values are means 6 SEM (n=3). For statistical analysis, one-way ANOVA, followed by
post hoc correction according to Tukey, was performed (*p,0.05). (C) Cell morphology. Alexa Fluor 546-conjugated phalloidin (red) and Hoechst
33258 (blue) fluorescence (left), DIC (middle), and the merged (right) images of C-9 and V1-69 are shown. Scale bar=10 mm.
doi:10.1371/journal.pbio.1000416.g004
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PLoS Biology | www.plosbiology.org 5 July 2010 | Volume 8 | Issue 7 | e1000416Figure 5. CP consists of two rigid domains and undergoes conformational changes. (A and B) Ribbon presentations of CPfull (orange) and
CPV-1 (purple). The ‘‘antiparallel H5s’’ are highlighted in cyan and the Ca atoms of CP (b) Leu40 and Arg66 are represented as gray balls. (C)
Superposition of CPfull (orange), CPbDC (green), and CPV-1 (purple) over the Ca positions of the entire CP molecule [residues 9–275 (a) and 3–244 (b)}.
(D) Superposition of the CP-L and CP-S domains. (E) Surface presentation of the CP-L (purple) and CP-S (cyan) domains. Note that the domain
boundary does not correspond to the subunit interface. (F and G) Twisting of CP-S relative to CP-L. CPfull (CP-L is shown in white), CPbDC (CP-L; gray),
and CPV-1 (CP-L; black) are superimposed over CP (a) 9–257 in CP-L. Two orthogonal views are shown. To facilitate comparison, some residues are
indicated as balls. In (G), CP-L was removed for clarity.
doi:10.1371/journal.pbio.1000416.g005
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hinges to facilitate domain movement.
Crystal Structures of the CP/CARMIL Peptide Complexes
To explore the structural basis of CP inhibition by CARMIL
proteins, we attempted to determine the structures of CP in
complex with CARMIL proteins. Since the CP-binding motif of
the CARMIL proteins is sufficient for the interaction with CP
[25], peptides derived from this motif were used for the
crystallographic studies; mouse CARMIL (residues 985–1005;
referred to as CA21), human CD2AP (485–507; CD23), and
human CKIP-1 (148–70; CK23) (we collectively refer to these
synthetic peptides derived from CARMIL proteins as CARMIL
peptides) (Figure 6A). In addition, we chose CPbDC for
crystallization, since the ‘‘b-tentacle’’ does not participate in the
CARMIL interaction [23]. All of the crystals were grown under
conditions similar to those for the ligand-free CPbDC, and the
structures were solved at 1.7–1.9 A ˚ resolutions (R=0.184–0.213,
Rfree=0.238–0.263) (Table S1).
The three crystal structures are shown in Figure 6B–D. As
expected from the sequence similarity, all three peptides bound to
essentially the same surface on CP. A superposition of the three
structures further highlights the structural similarity, especially in
their N-termini (Figure 6E). In contrast, the C-termini showed
some diversity, probably due to the lack of consensus residues and
the different peptide lengths. The peptides in our structures are
largely unfolded, as previously indicated by a circular dichroism
analysis [23]. Each elongated peptide binds along a continuous
curved groove on the surface of the CP b-subunit. The peptides
are bent by 100u at the conserved proline residue in the middle of
the CP-binding motif. The consensus motif interacts with CP
across the two domains: the N-terminus with the CP-L domain
and the C-terminus with the CP-S domain (Figure 6E). The
conformations of CP within the CP/CARMIL peptide complexes
are similar to each other (RMSDs; 0.71–0.90 A ˚) and are slightly
different from either CPfull or CPbDC (RMSDs; 0.97–1.26 A ˚)
(Table S3), suggesting that, unlike V-1, the CARMIL peptides do
not cause a large conformational change to CP.
Figure 6. Crystal structures of CP/CARMIL peptide complexes. (A) Sequence alignment of the CARMIL peptides used for crystallization.
Conserved residues in the CP-binding motif are highlighted in red. The critical arginine important for the binding of CP is indicated by an asterisk. (B–
D) Structures of CP in complex with CA21 (B; red), CD23 (C; orange), and CK23 (D; blue). (E) Superposition of the three peptides. The CP-L (purple) and
CP-S (cyan) domains are shown as surface models. The Ca atoms of conserved residues are shown as balls.
doi:10.1371/journal.pbio.1000416.g006
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primarily mediated by electrostatic interactions, which are
supported by hydrophobic interactions (Figures 7A and S5). The
mutation of a conserved arginine in the middle of the motif
(Arg493 in CD23; indicated by an asterisk in Figure 6A) reportedly
abolished CP binding for all of the peptides [23,25,31]. This
central arginine makes multiple interactions with both the CP-L
and CP-S domains, by forming a salt bridge with CP (b) Asp44,
and hydrogen bonds with CP (b) Ser41 and Tyr64 (Figure 7B). We
confirmed the importance of the intermolecular interface residues
of CP by biochemical assays using mutant CP proteins (Figure 8
and Table 1). Among the mutant CP proteins, CP (b) D44N
exhibited the lowest affinity for the CARMIL peptides.
The C-Terminal Flanking Region of the CP-Binding Motif
Is Required for High Affinity CP Binding
In addition to their extensive interactions through the CP-
binding motif, CD23 and CK23 further associate with the CP ‘‘N-
stalk’’ via the C-terminal flanking residues of the motif. In the CP/
CD23 complex, CD Phe505 contacts the hydrophobic pocket
formed by the CP ‘‘N-stalk’’ residues [CP (b) Ile29, Cys36, and
Leu40] and the peptide residues (CD Leu501 and Pro502) (Figure
S6A). In the CP/CK23 complex, the C-terminal residue of the
peptide, CK Arg169, forms an electrostatic interaction with CP (b)
Asp30 (Figure S5B). In contrast to these two peptides, CA21 does
not contact CP via the C-terminal flanking region (Figures 9A and
S5A).
We tested the importance of the C-terminal flanking regions of
the CP-binding motif using a binding assay (Table 2; the
constructs used for the measurement are shown in Figure 9B).
Surprisingly, GST-CD43, lacking CD Phe505 but containing the
entire consensus motif, bound to CP only weakly with a KD of
260 nM, suggesting that the CP-binding motif of CD2AP alone is
not sufficient for stable interaction with CP. In contrast, longer
constructs with extended C-terminal residues showed higher CP
binding affinities than the shorter fragments. GST-CD47,
containing CD Phe505, bound to CP with a KD of 18 nM and
GST-CD56 bound tightly to CP (KD=4.7 nM), in good
agreement with the previously reported value (KD=5.6 nM for
GST-CD2AP fragment containing residues 474–513 [25]). The C-
terminus of CD23 extends into the region between the CP-L and
CP-S domains (Figure S6B). Thus, the residues immediately C-
terminal to CD23 (i.e., CD Gly508,) are expected to form
additional contacts with the domain boundary residues to stabilize
the CP/CD2AP complex. Collectively, the C-terminal flanking
region of the consensus motif is required for the stable interaction
between CP and CD2AP.
We also examined GST-CARMIL fragments (Table 2 and
Figure 9C). Both GST-CA55 and GST-CA63, containing the
entire CP-binding motif and 10 or more extra residues at either
end, bind only to CP with KDs in the micromolar range. This
confirms that the consensus motif alone cannot tightly bind to CP.
Moreover, unlike CD2AP, the CARMIL residues immediately C-
terminal to the motif do not contribute to the stable CP
interaction, consistent with our structure in which CA21 does
not contact CP in this region. The stable CP interaction was
observed in longer CARMIL fragments. GST-CA76 was found to
have modest binding affinity to CP (KD=80 nM) and GST-CA92
bound strongly to CP (KD=3.3 nM) and with a comparable KD
to GST-CD56.
We next evaluated the CP-binding affinity of CK23 by a
competition assay and found that both CD23 and CK23
effectively compete with immobilized GST-CA92 for CP binding,
whereas CA21 was a less efficient competitor (Figure S7). Thus,
CK23 appears to have CP binding affinity comparable to CD23.
Figure 7. The molecular interface between CP and CARMIL peptides. (A) The intermolecular interactions between residues of CP and
CD23. CD23 is shown as a stick model and the labels are underlined. Conserved residues are highlighted in orange. The colored surfaces [CP-L
(purple) and CP-S (cyan)} indicate the interface residues. Note that all of the contact residues reside in the CP b-subunit, except for Phe168 (a).
(B) Interaction between CD Arg493 and CP b-subunit residues. Salt bridges and hydrogen bonds are indicated by dotted lines with distances in
angstroms.
doi:10.1371/journal.pbio.1000416.g007
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correlated with their ability to inhibit the barbed end capping.
CD23 and CK23 moderately inhibited barbed end capping by
CP, while CA21 was a poor inhibitor (Figure 9D). Furthermore,
CD30, a peptide with 7 extra residues at the C-terminus of CD23,
showed higher CP inhibition activity than CD23 (Figure 9D).
Although weaker than CD23 or CK23, CA21 retained the ability
to inhibit CP, since CA21 attenuated the barbed end capping by
CPbDC (Figure 9E), which is a less potent capper compared to
CPfull [4]. Intriguingly, all peptides tested effectively inhibited
CPbDC, suggesting that CARMIL peptides do not inhibit CP
simply by preventing the ‘‘b-tentacle’’ from filament binding. We
next tested the CP inhibitory activity of GST-CARMIL
constructs. As expected from their CP binding affinities, GST-
CA92 showed the strongest CP inhibitory effect (Figure 9F). GST-
CA92 appears to have full CP inhibition activity, because it
showed a similar level of inhibition as GST-C-1 (residues 962–
1084), which has the same activity as the full length CARMIL
(unpublished data [23]).
CARMIL Peptides Do Not Sterically Inhibit CP
A superposition of the crystal structures of the CP/CARMIL
peptide complexes onto the EM model of the CP/actin filament
structure clearly revealed that none of the peptides on CP overlap
with the barbed end actin protomers (Figure 10). As described
above, all of the peptides used for the crystallization have varying
degrees of CP inhibition activity (Figure 9D–F). Furthermore, the
C-terminal flanking residues of CD23, which greatly contribute to
the CP inhibition, cannot reach the nearest surface of the actin
filament. Therefore, unlike V-1, the CARMIL peptides do not
inhibit the barbed end capping activity of CP by steric hindrance.
This non-overlapping CP interaction, permitting the CARMIL
peptides to interact with the filament-bound CP, is a prerequisite
for the uncapping activity. Furthermore, the ‘‘a-tentacle’’
including the ‘‘basic triad’’ on the top surface of CP, the primary
actin binding site, is still exposed even when CP is bound with
CARMIL proteins. This allows the CP/CARMIL protein
complex to make an initial contact with the barbed end, and
thus CARMIL proteins cannot sequester CP completely from the
barbed end.
CARMIL Peptides Allosterically Inhibit CP/V-1 Binding
The CP binding site of V-1 is located on an opposite face from
the CARMIL peptide binding site, implying that CP can
simultaneously bind both inhibitors. Conversely, we found that
the conformation of CPV-1 is significantly different from that of the
CARMIL peptide-bound CP (CPCARMILs) (Table S3), because the
binding of V-1 induces a twisting movement of the CP-L and CP-
S domains. This raises the possibility that the CARMIL peptides
allosterically inhibit CP from binding V-1 by restricting the
domain twisting, since the peptides bind to CP across the two
domains. We tested this prediction using a surface plasmon
resonance assay. We immobilized GST-V-1 on a sensor chip, and
then perfused with CP premixed with CARMIL peptides.
Surprisingly, CD23 and CK23, which possess substantial affinity
for CP, strongly inhibited the CP/V-1 interaction, indicating that
the peptides restrict the conformation of CP to the ‘‘low affinity to
V-1’’ form (Figure 11A). This inhibition depends on the CP/
CARMIL peptide interaction because CA21, which has a lower
Table 1. Binding affinities between mutant CPs and CARMIL
proteins fragments.
Immobilized/Analyte Kon (M
21s
21)K off (s
21)K D (nM)
GST-CD56/CP (b) D44N
b — .0.1 16,000
GST-CD56/CP (b) D63N
b — .0.1 1,200
GST-CD56/CP (b) Y64F
a 9.9610
5 5.2610
23 5.2
GST-CD56/CP (b) D67N
b — .0.1 8,500
GST-CA92/CP (b) D44N
b — .0.1 7,400
GST-CA92/CP (b) D63N
b — .0.1 1,400
GST-CA92/CP (b) Y64F
a 4.6610
5 4.6610
23 10
GST-CA92/CP (b) D67N
b — .0.1 4,900
aKD values were calculated from the kinetic rate constants (KD=k off/kon).
bKD values were obtained from Michaelis-Menten plots under saturated binding
conditions.
doi:10.1371/journal.pbio.1000416.t001
Figure 8. CP (b) D44N is less sensitive to CARMIL proteins. Actin (1.2 mM; 5% pyrene-labeled) was polymerized from spectrin-actin seeds in the
presence of 4 nM wild type CP or CP (b) D44N (a mutant CP deficient for CARMIL peptide interaction; see Table 1). CP (b) D44N has identical capping
activity to the wild type. As expected, CARMIL constructs cannot effectively prevent the mutant CP from capping actin filaments.
doi:10.1371/journal.pbio.1000416.g008
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inhibition (Figure 11A). Furthermore, none of the peptides tested
could prevent CP (b) D44N, a mutant CP deficient in CARMIL
protein interaction (Table 1 and Figure 8), from the V-1 interaction
(Figure 11B). Most notably, in addition to its effect on free CP, the
CARMIL peptides can act on CP pre-bound to V-1 and facilitate
the dissociation of the complex. When the preformed CP/V-1
complex bound on the sensor chip was perfused with CD23 or
CK23, CP dissociated from V-1quite rapidly, as compared with the
buffer control (Figure 11C). Again, we found that CA21 was less
effective in facilitating the dissociation (Figure 11C), and that the
interaction between CP (b) D44N and V-1 was not affected by
CARMIL peptides (Figure 11D). This result suggests that the
CARMIL peptides possess the ability to interact with CP in a
conformation different from CPCARMILs and to shift the CP
conformation toward the CPCARMILs form.
We further confirmed the effect of the CARMIL peptides on
CP/V-1 interaction by a pull-down assay. Under equilibrium
conditions, the binding of CP to GST-V-1 was inhibited by the
addition of the peptides in a concentration-dependent manner
(Figure S8). Collectively, we concluded that the CARMIL peptides
allosterically inhibit CP binding to V-1.
Figure 9. The importance of the C-terminal flanking region of the CP-binding motif. (A) Superposition of the C-termini of the peptides. CD
Phe505 and CK Arg169 are shown as stick models. The conserved proline at the C-terminus of the motifs is shown as balls. (B) CD2AP constructs used
for biochemical assays. (C) CARMIL constructs used for biochemical assays. (D–F) The effect of CARMIL fragments on the barbed end capping activity
of CP was measured for the ability to increase the actin elongation rate in the presence of CP. Actin (1.2 mM, 5% pyrene-labeled) was polymerized
from spectrin-actin seeds in the presence of 3.6 nM CPfull (D), 10 nM CPbDC (E), or 7.2 nM CPfull (F) with various concentrations of CARMIL peptides or
GST-CA constructs.
doi:10.1371/journal.pbio.1000416.g009
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To further explore the intrinsic flexibility of the CP molecule,
we performed a normal mode analysis with an elastic network
model (ENM). In this model, a protein is considered as a simple
elastic object, and the spatially neighboring residues in the native
structure are connected by Hookian springs. Based on this
approximation, the intrinsic fluctuations originating from the
protein shape are revealed. The normal mode analysis on the
ENM has been applied to various sizes of proteins, e.g., lysozyme
[32], F1-ATPase [33], and chaperonin GroEL [34]. Referring to
the lower frequency modes, the analysis succeeded in reproducing
large conformational motions that had been experimentally
revealed [35]. We applied this method to the CP/CD23 complex
(Figure 12A) and the CP structure extracted from the complex
(Figure 12B), and focused on the first lowest modes. The first
lowest mode of CP can be described as twisting motions relative to
two axes, which run through the a- and b-subunits, respectively
(Figure 12A and Table S4; see Materials and Methods for more
details). In this mode, the directions of the twisting movements
about the two axes are opposite from each other (indicated by
black and gray sets of arrows in Figure 12). Among these two axes,
the b-subunit axis almost coincides with the axis of the twist
movement between the CP-L and CP-S domains that was revealed
by the structural comparison (red rods with asterisk in Figure 12).
This finding strengthens the notion that CP continually undergoes
substantial twisting movements about this axis. Furthermore, we
found that the CARMIL peptides alter this intrinsic mode, both in
the direction of the rotational axis and the amplitude of the motion
(Figure 12B). These effects are observed almost exclusively in the
twisting motion about the b-subunit axis, yet not about the a-
subunit axis, suggesting that the CARMIL peptide suppresses the
twisting movement between the CP-L and CP-S domains.
Discussion
Mechanism of CP Regulation by V-1
The crystal structure of the CP/V-1 complex revealed that V-1
mainly interacts with the ‘‘a-tentacle,’’ the primary actin binding
surface of CP, thereby sterically hindering CP from barbed end
capping (Figures 1–3). The structure supports biochemical data
that V-1 has no uncapping activity (Figure 13D). A sequence
alignment of V-1 indicates that the residues involved in the V-1
interaction are highly conserved through evolution, despite their
relatively minor contributions to the protein fold (Figure S9).
Furthermore, the ‘‘basic triad’’ in the CP a-subunit, containing the
highly conserved residues critical for actin binding is also
recognized by V-1. This suggests that the architecture of the V-
1 molecule is well suited for the interaction with CP, i.e., CP
inhibition is the key role for V-1 in various cellular processes. This
notion is further supported by the finding that, in cultured cells, V-
1 is involved in the regulation of actin assembly and cell
morphology (Figure 4). We note that CARMIL peptides inhibit
CP from binding V-1 (Figures 11 and S8), indicating that the effect
of V-1 on CP may be under the control of other proteins which
interact with CP or V-1. Future studies will verify the role of V-1
in actin-driven cell motility.
Conformational Flexibility of CP and the Barbed End
Capping
An unexpected finding in this study was the conformational
flexibility of the CP molecule. A structural comparison analysis
revealed that CP consists of two rigid domains, CP-L and CP-S,
and undergoes conformational changes even in the absence of a
ligand (Figure 5). This intrinsic twisting motion between the two
CP domains was further supported by a normal mode analysis of
free CP (Figure 12A). Intriguingly, our analysis also predicts that,
in addition to the domain twist related to the rotational axis
passing through the b-subunit, there might be an analogous
twisting movement about the a-subunit axis. This is plausible
because CP has pseudo 2-fold rotational symmetry [3]. Thus, the
CP-L domain might be further divided into two rigid subdomains,
which also undergo a twisting movement relative to each other.
Our data showed that the CP-binding motif of CARMIL
proteins cannot bind tightly to CP, despite the multitude of
intermolecular interactions present in the structures (Figures 7, 9,
S5, and Table 2). This is attributable to the conformational
fluctuation of CP, as the consensus motif interacts with residues at
the domain boundary that may act as a hinge in the twisting
movement. We demonstrated that the regions C-terminal to the
CP-binding motif are responsible for the strong interactions
Table 2. Binding affinities between CP and CARMIL peptides.
Immobilized Residues kon (M
21s
21)k off (s
21)K D (nM)
GST-CD43 461–503 — .0.1 260
a
GST-CD44 461–504 5.4610
5 0.033 62
b
GST-CD47 461–507 1.6610
6 0.029 18
b
GST-CD50 461–510 1.2610
6 0.018 15
b
GST-CD56 461–516 1.3610
6 5.9610
23 4.7
b
GST-CA55 962–1016 — .0.1 4,000
a
GST-CA63 962–1024 — .0.1 3,300
a
GST-CA76 962–1037 2.3610
5 0.019 80
b
GST-CA92 962–1053 1.6610
6 5.2610
23 3.3
b
aKD values were calculated from the kinetic rate constants.
bKD values were obtained from Michaelis-Menten plots under saturated binding
conditions.
doi:10.1371/journal.pbio.1000416.t002
Figure 10. CARMIL peptides do not directly compete with the
barbed end for CP binding. Superposition of the CP/CARMIL
peptide complex structure on the EM model of the CP/barbed end
structure using the Ca positions of CP (b) 3–244. The barbed end (gray)
and the penultimate (white) protomers are shown as surface models.
doi:10.1371/journal.pbio.1000416.g010
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motif and the flanking region may reciprocally increase their
affinity for CP, which in turn would inhibit CP effectively.
The tight interaction between CP and the barbed end is
contributed by the extensive inter-molecular surface residues [5].
Consequently, the intrinsic twisting motion between the two CP
domains that can cause changes in the overall structure must affect
the capping activity of CP. Therefore, for a stable filament
capping, CP accommodates its shape to a favorable conformation
for the barbed end interaction. Consequently, we have revised the
previous two-step capping model [5] as follows: (i) ‘‘Basic triad’’
residues on the CP ‘‘a-tentacle’’ region interact electrostatically
with the barbed end. This initial contact is followed by two
independent stabilization steps: (ii) an adaptive conformational
change to a ‘‘high affinity to the barbed end’’ form that is a
twisting movement between the CP-L and CP-S domains and (iii)
the supportive binding of the ‘‘b-tentacle’’ to the filament
(Figure 13B). Hence, a factor which disturbs either of the capping
steps has an inhibitory effect on the filament capping activity of
CP. For example, V-1 sterically hinders CP from the barbed end
by blocking step (i).
CARMIL Proteins Allosterically Inhibit CP by Suppressing
Its Conformational Fluctuations
How do CARMIL proteins inhibit the capping activity of CP in
an allosteric manner? We showed that CARMIL peptides
allosterically inhibit the interaction of CP with V-1 (Figures 11
and S8). This finding indicates that, regardless of the initial CP
state (i.e., free or V-1-bound), the peptides binding across the two
CP domains shift the conformational distribution to within a
narrow range around CPCARMILs, conformations that are
unfavorable for V-1 binding. We propose that CARMIL proteins
inhibit CP in a similar manner (Figure 13C); CARMIL proteins
limit the conformational distribution of CP to mostly the ‘‘low
affinity to the barbed end’’ form, leading to attenuation of the
barbed end capping activity [i.e., step (ii) in Figure 13B is
inhibited]. Fujiwara et al. indicated that CARMIL does not affect
the association of CP to the barbed end but accelerates its
dissociation from the filament since the on rate of the CP/
CARMIL complex to the barbed end is virtually the same as that
of free CP (3.7 mM
21s
21 versus 2.6 mM
21s
21), while the affinity of
the complex to the filament is significantly lower than that of free
CP (KD=38 nM versus 0.18 nM)[29]. This is consistent with our
hypothesis that the CARMIL proteins inhibit CP only by affecting
the twisting motion which provides the capping stability, since our
data showed that neither the ‘‘a-tentacle’’ (the capping on rate
determinant) nor the ‘‘b-tentacle’’ (the other capping stabilizer) is
disturbed by the CARMIL protein. Furthermore, our prediction
that the conformation CPCARMILs is substantially different from
the ‘‘high affinity to the barbed end’’ form is consistent with the
concept that CARMIL binding to free CP must involve some
surface or conformation that is not available when CP is bound to
a barbed end [23]. This is because the affinity of CARMIL for the
barbed end-bound CP has been estimated to be 10- to 100-fold
[23] or 200-fold [29] lower than that for free CP.
To better understand the mechanism of CP inhibition by the
CARMIL proteins, it would be helpful to know the conformation
Figure 11. CARMIL peptides allosterically inhibit CP/V-1 binding. The ability of CARMIL peptides to inhibit CP binding to V-1 was tested by a
surface plasmon resonance assay. GST-V-1 was immobilized on a sensor chip. (A and B) Mixtures of 100 nM CARMIL peptides and 45 nM CP wt (A) or
CP (b) D44N (B) were perfused to assess the effect of the peptides on the formation of the CP/V-1 complex. (C and D) Initially, 45 nM CP wt (C) or CP
(b) D44N (D) was perfused to form the GST-V-1/CP complex, and subsequently 100 nM CARMIL peptides were perfused to observe the effect of the
peptides on the dissociation of CP from the immobilized GST-V-1.
doi:10.1371/journal.pbio.1000416.g011
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structures of CP to the 3D electron density map of the CP/actin
filament [5] and found that all of the structures tested fit similarly
to the model except for CPV-1, which did not fit as well (Figure
S10). The mismatch between the EM envelope and CPV-1 is
largely due to the shift of the CP-S domain relative to the CP-L
domain, suggesting that the CP in the ‘‘high affinity to the barbed
end’’ form may not adopt such an ‘‘open’’ conformation as in
CPV-1.
In this study, we cannot provide structural information about
CP bound to the full activity CARMIL fragments. During the
submission of this manuscript, Robinson and colleagues reported a
crystal structure of CP in complex with a CARMIL fragment with
an extended C-terminal portion (CBR115; human CARMIL
residues 964–1078) [36]. This structure revealed that, in addition
to the CP-binding motif, a 15 residue motif serves as a second CP
binding site (CARMIL-specific interaction motif, residues 1021–
1035; highlighted by orange in Figure S11). The motif binds to the
CP ‘‘N-stalk’’ in the CP-L domain, on the side opposite to where
the CP-binding motif binds. This result also supports the concept
that CARMIL proteins inhibit CP in an allosteric manner (see
Text S1 for a detailed discussion about the role of the C-terminal
flanking region of the CP-binding motif of the CARMIL proteins
for CP inhibition).
Recently, intrinsically unstructured proteins or segments of
proteins have been recognized to play critical roles in many
cellular processes such as transcriptional regulation and signal
transduction [37]. These disordered regions usually fold into
ordered secondary or ternary structures upon binding to their
targets (termed coupled folding and binding processes). We
revealed, however, that the CARMIL peptides are functional in
suppressing the conformational flexibility of CP, although they
have an extended backbone conformation. Consequently, our
results provide new insights into the functional expression of
intrinsically unstructured proteins.
Implications for Dynamic CP Behavior in Cells
An important implication of this study is that conformational
restraints placed on CP lead to an attenuated affinity of the
protein for the barbed end. This raises the possibility that other
CP regulators, such as PIP2, also modulate the capping activity.
Moreover, the state of the actin filament would also affect the
affinity of CP towards the filament; i.e., a certain actin binding
protein that changes and/or restricts the structure of the barbed
end to an unfavorable form for CP binding can antagonize the
filament capping. We assume that such a mechanism may
account for the rapid turnover rate of CP in lamellipodia
[9,10].
In this study, we have described the structural basis for CP
inhibition by two regulators, V-1 and CARMIL proteins. Our
findings suggest that CP is not a constitutively active inhibitor
of barbed end elongation; rather, the capping activity of CP is fine-
tuned for the highly orchestrated assembly of the cellular actin
machinery, and the conformational flexibility of CP provides the
structural basis for the regulation.
Materials and Methods
Proteins
Expression vectors for chicken CPfull and CPDbC were
constructed in pETDuet-1 by PCR, using pET-3d/CP [38] as
the template. CP was expressed in E. coli Rosetta2 (DE3) and was
purified as described [3]. V-1 (human), expressed in E. coli
Rosetta2 (DE3) as a GST-fusion protein, was affinity-purified and
Figure 12. Normal mode analysis supports the intrinsic flexibility of the CP molecule. Free CP (A) and the CP/CD23 complex (B) are shown.
Two rotational axes of the first mode, which run through the a- (cyan) and b-subunits (magenta), respectively, are presented. The directions of the
motion are indicated by black and gray sets of arrows. Whiskers indicate the relative amplitudes of positional fluctuations of Ca associated with the
first slowest mode. Red rods with an asterisk indicate the rotational axis of the twist movement between the CP-L and CP-S domains, determined
from a comparison of the crystal structures.
doi:10.1371/journal.pbio.1000416.g012
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proteins were obtained from Invitrogen. For crystallization, CP
was incubated with a 1.2–2.0-fold molar excess of V-1 or
CARMIL peptides at 4uC for 2 h, followed by gel filtration to
purify the complexes. Expression vectors for the GST-CA
constructs were prepared from the mouse cDNA clone as
previously described [23]. Vectors for GST-CD fragments were
constructed by PCR cloning using a human whole brain cDNA
library (Clontech) as the template. Amplified DNA fragments
were cloned into pGEX-6P-1. GST-fusion proteins were
expressed in E. coli Rosetta2 (DE3) cells and affinity-purified
using glutathione sepharose resin. Mutations were introduced
using a Quikchange mutagenesis kit (Stratagene). Actin was
prepared from rabbit skeletal muscle, as previously described
[39], and was further purified by gel filtration chromatography.
Pyrene labeled-actin was prepared as described [40]. Spectrin-
actin seeds were prepared from rabbit red blood cells, as
previously described [41].
Figure 13. Model for the filament capping by CP and its inhibition by V-1 and CARMIL proteins. (A) Free CP is in equilibrium between
pre-existing multiple conformations, which can be attributed to the twisting movement between the CP-L (purple) and CP-S (cyan) domains. The
affinity of CP for the barbed end is dependent on its conformation. (B) The barbed end capping by CP. (i) ‘‘Basic triad’’ residues on the CP ‘‘a-tentacle’’
region (blue star) interact electrostatically with the barbed end. This initial contact is further stabilized by (ii) an adaptive conformational change to a
‘‘high affinity to the barbed end’’ form and (iii) a supportive binding of the ‘‘b-tentacle’’ (yellow) to the filament. (C) CARMIL proteins allosterically
inhibit CP by disturbing its conformational flexibility [i.e., preventing step (ii) in (B)}. In free CP inhibition (red arrow) CARMIL proteins bind toC P
across the two domains, thus restraining the twisting motion. In uncapping (blue arrow), CARMIL proteins interact with the barbed end-bound CP.
This is possible because the binding site is not hindered by the actin protomers. In either process, CARMIL proteins shift the conformational
equilibrium of CP toward the ‘‘low affinity to the barbed end’’ form, thereby attenuating the capping activity. Note that the CP bound CARMIL
proteins do not directly affect the a-o rb-tentacle interactions to the filament. (D) In contrast to CARMIL proteins, V-1 sterically hinders CP from the
barbed end by interacting with its primary actin binding site, thereby abolishing the filament capping activity [i.e., step (i) in (B) is inhibited}.
Simultaneously, V-1 lacks uncapping activity, because the V-1 binding site on CP is buried deeply between the two end protomers when CP caps the
filaments. Note that V-1 binding must affect the conformational flexibility of CP, since it holds CP in the CPV-1 conformation. However, this effect
appears not to be the main cause of CP inhibition by V-1.
doi:10.1371/journal.pbio.1000416.g013
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Determination
Each protein complex, at 8–10 mg/ml in 1 mM DTT and
5 mM Tris-HCl (pH 8.0), was mixed with an equal volume of
reservoir solution as follows: 10% PEG4000, 20% isopropanol,
20 mM EDTA, 0.1 M Tris-HCl (pH 8.4) for CP/V-1; 12.5%
PEG400, 20 mM BaCl2, 0.1 M MES-NaOH (pH 6.0) for CPbDC;
18% PEG400, 40 mM BaCl2, 0.1 M MES-NaOH (pH 6.0) for
CP/CA21; 10% PEG400, 20 mM BaCl2, 0.1 M MES-NaOH
(pH 6.5) for CP/CD23; and 17.5% PEG400, 30 mM BaCl2,
0.1 M MES-NaOH (pH 6.0) for CP/CK23. The crystals were
grown at 20uC by the hanging-drop vapor diffusion method and
were cryoprotected with their reservoir solutions supplemented
with 20% glycerol (for CP/V-1) or with 35% PEG400 (for other
crystals) prior to flash-cooling in a cold nitrogen stream.
Diffraction data were collected in the BL26B1 beamline at
SPring-8 [42] and were processed with HKL2000 [43]. Space
groups and cell parameters are listed in Table S1. Initial phases
were determined by molecular replacement with Molrep [44],
using the CP structure as a search model. Model building and
refinement were performed with CNS [45], Refmac [46], and
Coot [47]. Each crystal contains one CP or CP/inhibitor complex
in the asymmetric unit. Data collection and refinement statistics
are summarized in Table S1.
Actin Polymerization Assay
The barbed end elongation assay from spectrin-actin seeds was
performed essentially as previously described [4]. Briefly, G-actin
was stored in G-buffer (0.2 mM CaCl2, 0.2 mM ATP, 0.5 mM
DTT and 10 mM imidazole, pH 7.0). At 90 s prior to
polymerization, the Ca
2+ was replaced with Mg
2+, by the addition
of 1/10 volume of 10 mM EGTA and 1 mM MgCl2 to G-actin.
Barbed end elongation was initiated by mixing the solutions in the
following order: Mg
2+ actin (5% pyrene-labeled), CP, V-1 or
CARMIL protein, a 1/20 volume of 206 polymerization buffer
(1 M KCl, 20 mM MgCl2, 20 mM EGTA, 0.2 M imidazole,
pH 7.0) and spectrin-actin seeds. Actin polymerization was
measured by monitoring the pyrene-actin fluorescence (excitation
370 nm; emission 410 nm) at 25uC.
Surface Plasmon Resonance Measurements
The binding affinities of CP for V-1 or CARMIL proteins were
evaluated by surface plasmon resonance measurements with
Biacore 3000 or Biacore 2000 instruments (GE Healthcare).
GST-fusion proteins (GST-V-1, GST-CA, or GST-CD) were
immobilized onto a CM5 sensor chip up to 200 RU (response
units; 200 pg/mm
2) via anti-GST antibodies. CP at various
concentrations in running buffer (50 mM KCl, 1 mM MgCl2,
0.005% Tween-20, 10 mM imidazole, pH 7.0) was perfused over
the chip at 20uC, at a flow rate of 20 ml/min. Response curves
were obtained by subtracting the background signal generated
simultaneously on a control flow cell with immobilized GST. To
measure the effect of the CARMIL peptides on the facilitation of
CP/V-1 dissociation (in Figure 11C and 11D), we used the ‘‘co-
inject’’ mode for successive injections of the peptides followed by
CP. Kinetic parameters were determined by fitting the sensor-
grams to a simple 1:1 binding model, using the Bia-evaluation
software (GE Healthcare). KD values were obtained from the
kinetic rate constants. For several mutant proteins possessing fast
dissociation rates for the ligand (koff .0.1 s
21), we measured the
amount of bound-CP at the steady state over a wide concentration
range. KD values were evaluated by plotting these values against
the concentrations of CP.
Cultured Cell Analysis
The stable V-1 overexpression transfectant (V1-69) and its mock
transfectant (C-9), established in the PC12D subclone of rat
pheochromocytoma cells, were cultured as reported previously
[16]. The concentrations of F- and G-actin were measured using
an assay kit (Cytoskeleton), as described previously [48]. For
subcellular fractionation, the cells were homogenized by sonication
in homogenization buffer (150 mM NaCl, 2 mM EGTA, 10 mM
Tris-HCl, pH 7.4, with protease inhibitors). The extracts were
centrifuged at 100,000 g for 60 min, and the supernatant was
designated as the ‘‘high speed supernatant’’ fraction. The pellet
was incubated for 30 min in the homogenization buffer supple-
mented with 0.5% Triton X-100 and ultracentrifuged. This
supernatant was designated as the ‘‘high speed pellet soluble in
detergent’’ fraction, and the ‘‘high speed pellet insoluble in
detergent’’ fraction was obtained by further extraction of the pellet
in 8.3 M urea. The amount of CP in the fractions was determined
by Western blotting with an anti-CP b-subunit antibody [21]. For
morphological analysis, cells cultured at a density of 5610
4 cells
per well on the poly-D-lysine-coated culture slides (BD Biosciences)
for 24 h were fixed by 3.7% formaldehyde in PBS and
permeabilized with 0.1% Triton X-100 in PBS. Fixed cells were
pre-incubated with the Image-iT FX signal enhancer (Invitrogen)
and counter-stained with Alexa Fluor 546-conjugated phalloidin
(Invitrogen) and Hoechst 33258 (Dojin). The fluorescence images
were obtained using Leica microfluorescent system (AF6500; Leica
Microsystems).
Normal Mode Analysis by the ENM
The intrinsic flexibility of CP was examined by the normal mode
analysis with the ENM [49,50,51]. In this model, only the Ca
atoms are considered, and a harmonic potential with a single
parameter, C, is introduced between all Ca atoms within a cut-off
distance, RC~10:0 A ˚. The potential energy of a protein is given as
VENM~
1
2
X
Dr0
ijDvRC
C DrijD{Dr0
ijD
   2
,
where rij ~ri{rj
  
is the vector connecting the i-th and j-th Ca
atoms and r0
ij is that in the crystal structure. The Hessian matrix,
whose elements are the second derivatives of the potential energy,
was derived and diagonalized, and we obtained the eigenvectors
and eigenvalues, representing the normal modes.
Since the twisting movements were revealed by comparisons of
the crystal structures, we estimated the intrinsic rotations from the
lowest frequency mode that corresponds to the largest vibration.
As the CP free model structure, we employed the CP structure of
the CP/CD23 complex (i.e., the CD2 peptide was removed). The
displacements of each Ca atom were derived from the displace-
ment vector, the eigenvector of the lowest frequency mode scaled
by the reciprocal of the eigenvalue. We consider that the set of Ca
atoms with small displacements represents the rotation axis. The
Ca atoms, whose squares of the displacements were smaller than
2A ˚ 2, were collected.
We found that these Ca atoms could be clearly divided into two
groups, and each of them was separately distributed in the a-
subunit or the b-subunit (Table S4). The coordinates of these Ca
atoms in each group were evaluated by the principal component
analysis, and the first components defined the rotation axes on the
a- and b-subunits. In Figure 12, the axes run on the center of Ca
atoms with small displacements. The same analysis was applied to
the CP/CD23 complex, with a cut-off displacement of 1 A ˚ 2.
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The Protein Data Bank accession codes for the crystal structures
determined in this study are as follows: CP/V-1 (3AAA), CPbDC
(3AA7), CP/CA21 (3AA0), CP/CD23 (3AA6), and CP/CK23
(3AA1).
Supporting Information
Figure S1 Primary sequence of CP. The amino acid
sequences of the chicken CP a1-subunit (A) and b1-subunit (B)
are shown. Bars and arrows above the sequences represent a-
helices and b-strands, respectively; asterisks and exclamation
marks indicate the V-1 and CD23 interacting residues, respec-
tively. The loop S5–S6 (b), which is important for V-1 binding, is
indicated as a green wavy line. Residues in the CP-S domain are
highlighted in cyan. Each structural motif is indicated with a bar
underneath, in the colors corresponding to those in Figure 1A. At
the N-terminus, each CP subunit has three a-helices (we call this
region the ‘‘N-stalk’’). On each side of the ‘‘N-stalk,’’ short b-
strands are packed in a unique manner to form globular structures
that are flanked by helix 4 of either subunit (‘‘a-globule’’ and ‘‘b-
globule’’). A large anti-parallel b-sheet consisting of 10 b-strands
forms the central layer (‘‘central b-sheet’’). Helix 5 of both
subunits, containing a helix-breaking residue [Thr253 (a) and
Gly234 (b)], lies above the ‘‘central b-sheet’’ in an anti-parallel
fashion (‘‘antiparallel H5s’’), and each is flanked by C-terminal
extensions that possess barbed end capping activity (‘‘a-tentacle’’
and ‘‘b-tentacle’’).
Found at: doi:10.1371/journal.pbio.1000416.s001 (0.39 MB TIF)
Figure S2 V-1 mutants deficient in CP-binding fail to
inhibit CP’s capping activity. Actin (1.2 mM; 5% pyrene-
labeled) was polymerized from spectrin-actin seeds in the presence
of 3 nM wild type CP with various concentrations of wild type V-1
or mutant V-1 proteins. The addition of wild-type V-1 to the
system at a concentration well above the KD inhibited CP from
barbed end capping. In contrast, the CP-binding deficient V-1
mutants (V-1 W8A, D44R, or E78R; see Table S2) showed
minimal effects on CP capping.
Found at: doi:10.1371/journal.pbio.1000416.s002 (0.16 MB TIF)
Figure S3 Crystal structure of CPbDC. Crystal structure of
CPbDC (chicken a1 full/b1 1–244; a deletion mutant CP lacking
the ‘‘b-tentacle’’) at 1.9 A ˚ resolution. Two orthogonal views of the
structure are shown in ribbon models with the a-subunit (yellow)
and b-subunit (green). The N- and C-termini are indicated. The
secondary structures of CPbDC are nearly identical to those of
CPfull, although the overall conformations are significantly
different between the two structures (see Table S3).
Found at: doi:10.1371/journal.pbio.1000416.s003 (1.04 MB TIF)
Figure S4 Structural change to CP induced by V-1
binding. The C-terminal region of the CP a-subunit (residues
243–275) and the loop (b) S5–S6 are shown in ribbon models.
CPfull: CP-L (white) and CP-S (orange): CPV-1: CP-L (gray) and
CP-S (purple); V-1: magenta. Molecular interface residues [CP (a)
Lys256, Arg260 and Arg266, V-1 Trp8, Asp44 and Glu78] are
shown as stick models and hydrogen bonds are indicated by green
lines. Shifts of CPV-1 induced by the V-1 interaction are
represented by cyan arrows. Upon V-1 binding, the CP-S domain
rotates by approximately 10u relative to the CP-L domain about a
rotation axis that is nearly identical to the long axis of the molecule
(see Figure 5F and 5G). Since V-1 Glu78 interacts simultaneously
with CP (a) Lys256 near the domain boundary and with Arg266 in
the ‘‘a-tentacle,’’ it pulls Arg266 towards Lys256 by ,2.7 A ˚ (Ca
positions). This shift straightens the ‘‘antiparallel H5s’’ and further
moves the rest of CP-S bound tightly with the ‘‘a-tentacle.’’ As a
result, the distance between the ‘‘N-stalk’’ and ‘‘b-globule’’
becomes wider (see Figure 5A and 5B). Simultaneously, V-1
ANK 1 pushes down the CP (b) S5–S6 loop in CP-S by ,2.5 A ˚.
Found at: doi:10.1371/journal.pbio.1000416.s004 (0.40 MB TIF)
Figure S5 Residues at the intermolecular interface of
the CP/CA21 and CP/CK23 complexes. CP is presented as
a surface model with the residues contacting the peptides shown in
purple (CP-L domain) and cyan (CP-S domain). The residues of
the peptides are underlined. In (A), CA21 is shown as a gray stick
model and the conserved residues are highlighted in red. In (B),
CK23 is shown as a gray stick model and the conserved residues
are highlighted in blue. All of the peptides contact CP residues that
reside in the b-subunit, except for (a) Phe168 and Tyr199 (A) and
(a) Phe168 (B).
Found at: doi:10.1371/journal.pbio.1000416.s005 (1.12 MB TIF)
Figure S6 The importance of the C-terminal flanking
region of the CP-binding motif. (A) Interactions between the
C-terminus of CD23 and the CP-L domain. Interface residues are
shown as stick models. (B) Bottom view of CP/CARMIL peptide
complexes. CP is viewed from the ‘‘N-stalk.’’ CARMIL peptides
are shown as tubes. The Ca position of CD Gly507, the C-
terminal end residue of CD23, is shown as a green ball. Note that
the C-terminus of CD23 points toward the space between the ‘‘N-
stalk’’ and ‘‘b-globule.’’ Thus, extension of the peptide at the C-
terminus appears to provide additional contacts with CP.
Found at: doi:10.1371/journal.pbio.1000416.s006 (1.41 MB TIF)
Figure S7 CD23 and CK23 effectively compete with
GST-CA92 for CP binding. GST-CA92 was immobilized on a
sensor chip and then perfused with 50 nM wild type CP pre-mixed
with various concentrations of CARMIL peptides. The addition of
CK23 effectively inhibited CP from GST-CA92 binding, in a
similar manner as CD23. In contrast, CA21 was a less efficient
competitor. Note we could not increase the concentration of CA21
higher than 500 nM due to the solubility limit of the peptide.
Found at: doi:10.1371/journal.pbio.1000416.s007 (0.25 MB TIF)
Figure S8 CARMIL peptides inhibit CP binding to V-1 in
a pull-down assay. The effect of CARMIL peptides on CP/V-1
complex formation under equilibrium conditions was measured by
a pull-down assay. Glutathione sepharose beads were coupled with
2 mM GST-V-1. The beads were incubated for 2 h with 1 mMC P
in the presence of various concentrations of CD23 (A), CK23 (B),
or CD23 (C). Unbound and bound CP fractions were quantified
by SDS-PAGE with CBB staining. G, Glutathione beads were
coupled with 2 mM GST and were loaded with CP (no peptides).
V, GST-V-1 coupled beads were incubated in the absence of CP
and peptides. (D) The amounts of GST-V-1-bound CP in (A–C)
were plotted against the concentration of the CARMIL peptides
added: CD23 (orange triangle), CK23 (blue square), CA21 (red
circle).
Found at: doi:10.1371/journal.pbio.1000416.s008 (0.56 MB TIF)
Figure S9 Sequence alignment of V-1. The amino acid
sequences of V-1 proteins from various species were aligned by
ClustalW [52]. ANK1-4 denotes the ankyrin repeats. Bars above
the sequences represent a-helices or loops. Asterisks mark residues
contacting the CP a (yellow) or b (green) subunits. Strictly and
highly conserved residues are colored red and yellow, respectively.
For ANK2 and 3, the consensus sequence of the ankyrin repeat
proteins [53] is aligned below (x, any amino acid except cysteine,
glycine, or proline; z, any amino acid except histidine, asparagine,
or tyrosine; key residues for the structure are shown in red). A
comprehensive sequence analysis of ankyrin repeat proteins
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maintaining the folding characteristic of the ankyrin repeat
protein, a stack of helix-turn-helix bundles, and are well-conserved
in most repeats [54,55]. Note that the CP binding residues
including three critical residues, Trp8, Asp44, and Glu78, are
strictly conserved among the species, despite not being key residues
required for protein folding.
Found at: doi:10.1371/journal.pbio.1000416.s009 (0.80 MB TIF)
Figure S10 Fitting analysis of CP to the EM model of the
CP/actin filament structure. The atomic structures of CP in
different conformations were fitted to the 3D electron density map
of the CP/actin filament complex [5]. The contour level of the
EM envelope was set to 130%, and the orientations of CPfull (blue)
and CPV-1 (red) in the model are shown. The viewing angle of CP
is shown in the inset. Note that the conformation of CPfull provides
a better fit to the EM model than CPV-1. The cyan arrow indicates
a substantial mismatch between the envelope and CPV-1. Part of
the ‘‘b-globule’’ protrudes out of the envelope, due to the flatter,
opened conformation of CPV-1 as compared with CPfull (see
Figures 5A, 5B, and S4), implying that CP may not bind tightly to
the barbed end in the ‘‘open’’ conformation.
Found at: doi:10.1371/journal.pbio.1000416.s010 (0.49 MB TIF)
Figure S11 Sequence alignment of the CP-binding motif
with the C-terminal flanking region of CARMIL pro-
teins. The amino acid sequence of CARMIL (human, mouse,
Dictyostelium, and Acanthamoeba), CD2AP (human), and CKIP-
1 (human) are aligned. The CP-binding motif is highlighted in
magenta. Basic residues are indicated in blue. Asterisks denote the
C-terminus of the protein. During the preparation of this
manuscript, Robinson and colleagues reported the crystal
structure of CP in complex with a CARMIL fragment which
shows full CP inhibition activity (CBR115; human CARMIL
residues 964–1078)[36]. This structure revealed a 15 amino acid
residue motif that serves as the second CP binding site additional
to the CP-binding motif (CARMIL-specific interaction motif,
residues 1021–1035; highlighted in orange). Green arrows indicate
the C-terminus of CARMIL fragments, GST-CA76, or mCAH3
[29].
Found at: doi:10.1371/journal.pbio.1000416.s011 (0.33 MB TIF)
Table S1 Crystallographic statistics.
Found at: doi:10.1371/journal.pbio.1000416.s012 (0.05 MB
DOC)
Table S2 Binding affinities between CP and V-1.
Found at: doi:10.1371/journal.pbio.1000416.s013 (0.04 MB
DOC)
Table S3 Ca RMSDs between CP crystal structures.
Found at: doi:10.1371/journal.pbio.1000416.s014 (0.04 MB
DOC)
Table S4 Small displacement residues in normal mode
analysis.
Found at: doi:10.1371/journal.pbio.1000416.s015 (0.03 MB
DOC)
Text S1 Supplemental discussion. The role of the C-
terminal flanking region of the CP-binding motif in the CARMIL
proteins.
Found at: doi:10.1371/journal.pbio.1000416.s016 (0.04 MB
DOC)
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